FR0000073272 - Common Stock
SAFRAN SA
EPA:SAF (12/20/2024, 7:00:00 PM)
210
-1.2 (-0.57%)
Safran SA engages in the design, manufacture, and sale of aircraft, defense, and communication equipment and technologies. The company is headquartered in Paris, Ile-De-France and currently employs 91,984 full-time employees. The company went IPO on 2011-09-19. The Company’s segments are: Aerospace Propulsion, Aircraft Equipment and Aircraft Interiors. The Aerospace Propulsion segment designs, develops, produces, and markets, propulsion and mechanical power transmission systems for commercial aircraft, military transport, training and combat aircraft, civil and military helicopters, satellites, and drones. The company also includes maintenance, repair, and overhaul (MRO) activities and the sale of spare parts. The Aircraft Equipment segment operates in five main sectors: Landing and braking systems, Engine systems and equipment, Electrical systems, and engineering, Aerosystems, and Electronics & Defense. The Aircraft Interiors segment covers seats and cabin fittings, closets, in-flight entertainment systems and flight-deck equipment.
SAFRAN SA
2, Boulevard du General Martial Valin
Paris ILE-DE-FRANCE
P: 33140608080
Employees: 87055
Website: https://www.safran-group.com/
Find more stocks on Euronext Paris - Matif
Find more stocks on the EuroNext
Find more stocks on the European
Find competitors from the same sector on the EuroNext
Find competitors from the same industry on the EuroNext
Find stocks with similar TA and Setup ratings on the EuroNext
Find stocks with similar Fundamental rating on the EuroNext
Find more growth stocks the EuroNext
Find the competitors with the best technical ratings on the EuroNext
Find the competitors with the best technical and setup ratings on the EuroNext
Find the competitors with the best fundamentals on the EuroNext
Find the competitors with the best valuation on the EuroNext
Find the competitors with the best dividend on the EuroNext
Find the competitors with the best analyst ratings on the EuroNext